Aberdeen Group’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-750
| Closed | -$36K | – | 921 |
|
|
2022
Q3 | $36K | Hold |
750
| – | – | ﹤0.01% | 925 |
|
|
2022
Q2 | $43K | Hold |
750
| – | – | ﹤0.01% | 948 |
|
|
2022
Q1 | $61K | Hold |
750
| – | – | ﹤0.01% | 975 |
|
|
2021
Q4 | $152K | Hold |
750
| – | – | ﹤0.01% | 1041 |
|
|
2021
Q3 | $202K | Hold |
750
| – | – | ﹤0.01% | 1035 |
|
|
2021
Q2 | $193K | Hold |
750
| – | – | ﹤0.01% | 1003 |
|
|
2021
Q1 | $225K | Hold |
750
| – | – | ﹤0.01% | 974 |
|
|
2020
Q4 | $191K | Hold |
750
| – | – | ﹤0.01% | 945 |
|
|
2020
Q3 | $186K | Hold |
750
| – | – | ﹤0.01% | 925 |
|
|
2020
Q2 | $261K | Hold |
750
| – | – | ﹤0.01% | 906 |
|
|
2020
Q1 | $201K | Hold |
750
| – | – | ﹤0.01% | 895 |
|
|
2019
Q4 | $243K | Sell |
750
-3,679
| -83% | -$1.19M | ﹤0.01% | 920 |
|
|
2019
Q3 | $1.21M | Sell |
4,429
-5,596
| -56% | -$1.53M | ﹤0.01% | 776 |
|
|
2019
Q2 | $5.35M | Sell |
10,025
-4,250
| -30% | -$2.27M | 0.01% | 626 |
|
|
2019
Q1 | $7.2M | Sell |
14,275
-686
| -5% | -$346K | 0.02% | 561 |
|
|
2018
Q4 | $7.44M | Buy |
14,961
+4,160
| +39% | +$2.07M | 0.02% | 500 |
|
|
2018
Q3 | $9.88M | Buy |
10,801
+7,536
| +231% | +$6.89M | 0.02% | 487 |
|
|
2018
Q2 | $2.39M | Buy |
3,265
+611
| +23% | +$448K | ﹤0.01% | 706 |
|
|
2018
Q1 | $4.23M | Buy |
2,654
+1,704
| +179% | +$2.72M | 0.01% | 577 |
|
|
2017
Q4 | $851K | Sell |
950
-466
| -33% | -$417K | ﹤0.01% | 743 |
|
|
2017
Q3 | $510K | Buy |
+1,416
| New | +$510K | ﹤0.01% | 754 |
|